CompletedNot Applicable

Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma

United States750 participantsStarted 2017-06-01

Plain-language summary

Prospective, multicenter, observational registry of myeloma patients undergoing hematopoietic progenitor cell mobilization for upfront autologous transplantation.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Myeloma patients ages 18-70 years. * Undergoing upfront autoHCT (≤12 months from start of initial therapy for myeloma). Exclusion Criteria: * Patients with light chain (AL) amyloidosis or myeloma with associated AL amyloidosis. * POEMS syndrome

What they're measuring

Total CD34+ cell yield on the first apheresis

Timeframe: 6/1/17-1/1/19

CD34+ cell yield

Timeframe: 6/1/17-1/1/19

Number of apheresis sessions

Timeframe: 6/1/17-1/1/19

Mobilization failure rates

Timeframe: 6/1/17-1/1/19

Trial details

NCT IDNCT03200626

SponsorMedical College of Wisconsin

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-09-29

View on ClinicalTrials.gov More Multiple Myeloma trials